Pasquale L. Fedele

858 total citations
24 papers, 388 citations indexed

About

Pasquale L. Fedele is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Pasquale L. Fedele has authored 24 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 9 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Pasquale L. Fedele's work include Multiple Myeloma Research and Treatments (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Pasquale L. Fedele is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Pasquale L. Fedele collaborates with scholars based in Australia, United States and France. Pasquale L. Fedele's co-authors include George Grigoriadis, Michael Löw, Stephen L. Nutt, Julie Tellier, Simon N. Willis, Wei Shi, Yang Liao, Stephen Opat, Jianan Gong and David C.S. Huang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Immunology.

In The Last Decade

Pasquale L. Fedele

21 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pasquale L. Fedele Australia 11 127 125 118 100 100 24 388
Harald Biersack Germany 13 116 0.9× 196 1.6× 219 1.9× 71 0.7× 242 2.4× 33 560
Normann Steiner Austria 14 108 0.9× 180 1.4× 219 1.9× 54 0.5× 191 1.9× 55 471
Danielle Shafer United States 12 85 0.7× 118 0.9× 169 1.4× 48 0.5× 151 1.5× 30 398
Susana Lisboa Portugal 12 110 0.9× 97 0.8× 241 2.0× 48 0.5× 93 0.9× 25 433
Ellen Neylon United States 12 371 2.9× 79 0.6× 156 1.3× 167 1.7× 227 2.3× 27 571
Daisy Moreno United States 7 70 0.6× 201 1.6× 178 1.5× 58 0.6× 61 0.6× 9 430
Sangeeta Nischal United States 5 80 0.6× 216 1.7× 254 2.2× 62 0.6× 128 1.3× 9 463
Mecide Gharibo United States 12 71 0.6× 146 1.2× 175 1.5× 49 0.5× 197 2.0× 34 400
Kazutaka Ozeki Japan 11 33 0.3× 242 1.9× 124 1.1× 56 0.6× 76 0.8× 42 385
JR Downing United States 10 143 1.1× 188 1.5× 140 1.2× 83 0.8× 97 1.0× 16 472

Countries citing papers authored by Pasquale L. Fedele

Since Specialization
Citations

This map shows the geographic impact of Pasquale L. Fedele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pasquale L. Fedele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pasquale L. Fedele more than expected).

Fields of papers citing papers by Pasquale L. Fedele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pasquale L. Fedele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pasquale L. Fedele. The network helps show where Pasquale L. Fedele may publish in the future.

Co-authorship network of co-authors of Pasquale L. Fedele

This figure shows the co-authorship network connecting the top 25 collaborators of Pasquale L. Fedele. A scholar is included among the top collaborators of Pasquale L. Fedele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pasquale L. Fedele. Pasquale L. Fedele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grigoriadis, George, Shaun Fleming, Pasquale L. Fedele, et al.. (2025). Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach. Internal Medicine Journal. 55(5). 749–759.
2.
Tellier, Julie, Junli Nie, Christopher S. Smillie, et al.. (2024). Unraveling the diversity and functions of tissue-resident plasma cells. Nature Immunology. 25(2). 330–342. 21 indexed citations
3.
Shortt, Jake, Pasquale L. Fedele, Michael Gilbertson, et al.. (2024). Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies. Pathology. 57(3). 340–347. 2 indexed citations
4.
Fedele, Pasquale L. & Stephen Opat. (2024). Chronic Lymphocytic Leukemia: Time to Care for the Survivors. Journal of Clinical Oncology. 42(17). 2005–2011. 5 indexed citations
5.
Fedele, Pasquale L., et al.. (2021). Targeted Therapy in Acute Lymphoblastic Leukaemia. Journal of Personalized Medicine. 11(8). 715–715. 19 indexed citations
6.
Fedele, Pasquale L., Yang Liao, Jianan Gong, et al.. (2020). The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival. Leukemia. 35(7). 2114–2118. 21 indexed citations
7.
Teh, Charis E., Jianan Gong, David Segal, et al.. (2020). Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells. Cell Death and Differentiation. 27(7). 2217–2233. 25 indexed citations
8.
Löw, Michael, Erica J. Brodie, Pasquale L. Fedele, et al.. (2019). IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis. Cell Reports. 29(9). 2634–2645.e5. 53 indexed citations
9.
Fedele, Pasquale L., Yang Liao, Jianan Gong, et al.. (2019). Loss of IRF4 Results in Multiple Myeloma Cell Apoptosis through the Transcriptional up-Regulation of the BH3-Only Proteins Bmf and BIM. Blood. 134(Supplement_1). 3103–3103. 1 indexed citations
10.
Castillo, Jorge J., Francesco Baldini, Emmanuelle Tchernonog, et al.. (2019). Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. 3 indexed citations
11.
Löw, Michael, Pasquale L. Fedele, Anna Kalff, et al.. (2018). DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma. Leukemia & lymphoma. 59(12). 2842–2846. 12 indexed citations
12.
Karnowski, Alexander, Pasquale L. Fedele, Sridurga Mithraprabhu, et al.. (2018). Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins. International Journal of Molecular Sciences. 19(8). 2161–2161. 17 indexed citations
13.
Slade, C, Samar Ojaimi, Sara Barnes, et al.. (2018). Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency. Allergy Asthma and Clinical Immunology. 14(1). 65–65. 7 indexed citations
14.
Löw, Michael, et al.. (2017). Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma. British Journal of Haematology. 182(5). 739–741. 1 indexed citations
15.
Fedele, Pasquale L., Gareth P. Gregory, Michael Gilbertson, et al.. (2016). Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma. Annals of Hematology. 95(4). 667–668. 15 indexed citations
16.
17.
Löw, Michael, et al.. (2016). Anabolic androgenic steroids, an easily forgotten cause of polycythaemia and cerebral infarction. Internal Medicine Journal. 46(4). 497–499. 4 indexed citations
18.
Cheah, Chan Y., Kirsten Herbert, Glen Kennedy, et al.. (2014). A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma. British Journal of Cancer. 111(6). 1072–1079. 89 indexed citations
19.
Fedele, Pasquale L., Michael B. Wheeler, Christopher Lemoh, & Sanjeev Chunilal. (2014). Immunochromatographic antigen testing alone is sufficient to identify asymptomatic refugees at risk of severe malaria presenting to a single health service in Victoria. Pathology. 46(6). 551–554. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harald Biersack Breakdown of academic impact, for papers by Normann Steiner Breakdown of academic impact, for papers by Danielle Shafer Breakdown of academic impact, for papers by Susana Lisboa Breakdown of academic impact, for papers by Ellen Neylon Breakdown of academic impact, for papers by Daisy Moreno Breakdown of academic impact, for papers by Sangeeta Nischal Breakdown of academic impact, for papers by Mecide Gharibo Breakdown of academic impact, for papers by Kazutaka Ozeki Breakdown of academic impact, for papers by JR Downing
Rankless by CCL
2026